EU Hub Release 1.20 and Schema 2026.1: What Pharmaceutical Companies Need to Prepare for 2027

The European Medicines Verification Organisation (EMVO) has published an important update for pharmaceutical companies and On-Boarding Partners (OBPs) connected to the European Medicines Verification System (EMVS). EU Hub Release 1.20, currently planned for January 2027, will introduce the new Schema 2026.1, together with upcoming changes to EU Hub endpoints and certificates. For Marketing Authorisation Holders […]